Peptide record

TPDB20338

Nigrocin-M1 Antibacterial Anticancer Antifungal Toxicity standard
21 amino acids
Basic Information
3D PDB MODEL
Drag to rotate. Click a residue or atom to inspect it; the selected residue is highlighted in amber.
TPDB20338
Nigrocin-M1
Antibacterial Anticancer Antifungal Toxicity
Anti-infective peptides Cancer-related peptides Toxicity and safety peptides
Peptipedia CancerPPD 2.0
standard
No
A 21-aa standard natural multi-activity (Antibacterial, Anticancer, Antifungal, and other sources) peptide sequence curated from Peptipedia and CancerPPD 2.0, with an available 3D structural model.
Sequence
GLLGKILGAGKKVLLGVSGLL
Physicochemical Analysis
C94H172N24O23
RNDCEQHMFPTWY
L
2006.55
10.84
3
0
11
+3
-1.10
1.257
180.95
Mammalian: 30 hour Yeast: >20 hour E.coli: >10 hour
0
0.00
1
Residue Composition
number
1
A
0
R
0
N
0
D
0
C
0
E
0
Q
6
G
0
H
1
I
7
L
3
K
0
M
0
F
0
P
1
S
0
T
0
W
0
Y
2
V
Amino Acid Distribution
A: 1 R: 0 N: 0 D: 0 C: 0 E: 0 Q: 0 G: 6 H: 0 I: 1 L: 7 K: 3 M: 0 F: 0 P: 0 S: 1 T: 0 W: 0 Y: 0 V: 2
Chemical Descriptors
21
C94H172N24O23
2006.55
10.84
+3
-1.10
1.257
Free
L
Linear
Free
Antimicrobial and Antitumor
Synthetic Analogue of Nigrocin M1
Evidence Records 12 records
Evidence 1 Activity

Activity

MIC
Antibacterial
4 µM

Target

S. constellatus B003 VISIT

Source & Reference

NA

Other

C 12,493 or B038 V1S1A or B042 V2E1A (MIC 4-16 uM), E.faecalis NCTC 12,697 (MIC >512 uM), S. constellatus B003 VISIT (MIC 4 uM), Gram- E. coli NCTC 10,418 (MIC 8 uM), K. pneumoniae ATCC 13,883 or ATCC 43,816 (MIC 8-16
Evidence 2 Activity

Activity

MIC
Antibacterial
32 µM

Target

Candida albicans NYCY 1467

Source & Reference

NA

Other

8-16 uM), P. aeruginosa ATCC 27,853 or ATCC 9097 or B004 V2S2B (MIC >256 uM), and fungus C. albicans NYCY 1467 (MIC 32 uM). Anticancer: H157 (IC50 24 uM), PC-3 IC50 31.27 uM0, U-251MG (IC50 25.06 uM), and MCF-7 (
Evidence 3 Activity

Activity

IC50
IC50 = 24 µM
Anticancer
24 µM

Target

Non-small cell lung cancer
H-157
Lung

Assay & Model

MTT assay
24-h

Source & Reference

CancerPPD 2.0
CancerPPD2
2022

Other

Source Activity Label Source Definition
Anticancer
CancerPPD 2.0 manually curated experimentally verified anticancer peptide/protein annotation.
Evidence 4 Activity

Activity

IC50
IC50 = 31.27 µM
Anticancer
31.27 µM

Target

Prostate cancer
PC-3
Prostate

Assay & Model

MTT assay
24-h

Source & Reference

CancerPPD 2.0
CancerPPD2
2022
Evidence 5 Activity

Activity

IC50
IC50 = 25.06 µM
Anticancer
25.06 µM

Target

Brain Tumor
U-251-MG
Brain

Assay & Model

MTT assay
24-h

Source & Reference

CancerPPD 2.0
CancerPPD2
2022
Evidence 6 Activity

Activity

IC50
IC50 = 24.60 µM
Anticancer
24.60 µM

Target

Breast Cancer
MCF-7
Breast

Assay & Model

MTT assay
24-h

Source & Reference

CancerPPD 2.0
CancerPPD2
2022
Evidence 7 Activity

Activity

MIC
Antifungal
4 µM

Target

S. constellatus B003 VISIT

Source & Reference

NA

Other

C 12,493 or B038 V1S1A or B042 V2E1A (MIC 4-16 uM), E.faecalis NCTC 12,697 (MIC >512 uM), S. constellatus B003 VISIT (MIC 4 uM), Gram- E. coli NCTC 10,418 (MIC 8 uM), K. pneumoniae ATCC 13,883 or ATCC 43,816 (MIC 8-16
Evidence 8 Activity

Activity

MIC
Antifungal
32 µM

Target

Candida albicans NYCY 1467

Source & Reference

NA

Other

8-16 uM), P. aeruginosa ATCC 27,853 or ATCC 9097 or B004 V2S2B (MIC >256 uM), and fungus C. albicans NYCY 1467 (MIC 32 uM). Anticancer: H157 (IC50 24 uM), PC-3 IC50 31.27 uM0, U-251MG (IC50 25.06 uM), and MCF-7 (
Evidence 9 Activity

Activity

18% Hemolysis
Toxicity
100 µM
Hemolytic Cytotoxic
18% Hemolysis | 100 | µM | target cell: Horse erythrocytes

Target

Horse erythrocytes

Source & Reference

NA
DBAASP
A novel antimicrobial peptide found in Pelophylax nigromaculatus | J Genet Eng Biotechnol | 2022
Evidence 10 Activity

Activity

LC50
Toxicity
30 µM
Cytotoxic
LC50 | 30 | µM | target cell: Human keratinocytes HaCat

Target

Human keratinocytes HaCat

Source & Reference

NA
DBAASP
A novel antimicrobial peptide found in Pelophylax nigromaculatus | J Genet Eng Biotechnol | 2022
Evidence 11 Activity

Activity

LC50
Toxicity
60 µM
Cytotoxic
LC50 | 60 | µM | target cell: Human microvascular endothelial cells HMEC-1

Target

Human microvascular endothelial cells HMEC-1

Source & Reference

NA
DBAASP
A novel antimicrobial peptide found in Pelophylax nigromaculatus | J Genet Eng Biotechnol | 2022
Evidence 12 Activity

Activity

Toxicity
Hemolytic Cytotoxic
Hemolytic_activity: Not available | Cytotoxicity: Not available

Target

erythrocytes

Source & Reference

NA
DRAMP
J Genet Eng Biotechnol. 2022 May 23 20(1):77.